In the regulator’s own words
"Starting July 1, 2026, Medicare covers these GLP-1 drugs: Foundayo® (tablet) · Wegovy® (injection or tablet) · Zepbound® (KwikPen® only. The program doesn’t cover single-dose Zepbound® vials or pens)."
"You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug)."
"Your prior authorization is valid (including for refills and dose changes) through December 31, 2027, unless you change GLP-1s."
This page reports what the regulator has published, in its words. It is not legal or medical advice.